Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis

被引：0
|
作者：
Padmanabha D. Shenoy
Manish Bavaliya
Sujith Sashidharan
Kaveri Nalianda
Sreelakshmi Sreenath
机构：
[1] Centre For Arthritis & Rheumatism Excellence (CARE),
[2] Department of Rheumatology,undefined
[3] Amrita Institute of Medical Sciences,undefined
[4] Department of Medicine,undefined
[5] Amrita Institute of Medical Sciences,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Scleroderma interstitial lung disease; Cyclophosphamide; Mycophenolate mofetil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 8 条
  • [1] Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
    Shenoy, Padmanabha D.
    Bavaliya, Manish
    Sashidharan, Sujith
    Nalianda, Kaveri
    Sreenath, Sreelakshmi
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [2] Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
    Wang, Pengfei
    Zhang, Li
    Guo, Qian
    Zhao, Lifen
    Hao, Yanyan
    OPEN MEDICINE, 2023, 18 (01):
  • [3] Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Xinyu Ma
    Rui Tang
    Mei Luo
    Zhuotong Zeng
    Yaqian Shi
    Bingsi Tang
    Rong Xiao
    Clinical Rheumatology, 2021, 40 : 3185 - 3193
  • [4] Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Ma, Xinyu
    Tang, Rui
    Luo, Mei
    Zeng, Zhuotong
    Shi, Yaqian
    Tang, Bingsi
    Xiao, Rong
    CLINICAL RHEUMATOLOGY, 2021, 40 (08) : 3185 - 3193
  • [5] Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease An Analysis of Scleroderma Lung Studies I and II
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Li, Ning
    Roth, Michael D.
    Khanna, Dinesh
    Hoffmann-Vold, Anna-Maria
    Kim, Grace
    Goldin, Jonathan
    Clements, Philip J.
    Furst, Daniel E.
    Elashoff, Robert M.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (07) : 1451 - 1460
  • [6] Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders
    Iudici, Michele
    Cuomo, Giovanna
    Vettori, Serena
    Bocchino, Marialuisa
    Zamparelli, Alessandro Sanduzzi
    Cappabianca, Salvatore
    Valentini, Gabriele
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (04) : 437 - 444
  • [7] Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus NephritisA Meta-Analysis of Randomized Controlled Trials
    Lin-lin Liu
    Yi Jiang
    Li-ning Wang
    Li Yao
    Zi-long Li
    Drugs, 2012, 72 : 1521 - 1533
  • [8] Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure
    Linn, Swe Mar
    Novitzky-Basso, Igor
    Patriquin, Christopher
    Pasic, Ivan
    Lam, Wilson
    Law, Arjun
    Michelis, Fotios, V
    Gerbitz, Armin
    Viswabandya, Auro
    Lipton, Jeffrey
    Kumar, Rajat
    Mattsson, Jonas
    Barth, David
    Kim, Dennis Dong Hwan
    LEUKEMIA RESEARCH, 2023, 134
1